Agile Therapeutics Announces Pricing of $24M Upsized Public Offering
Agile Therapeutics, Inc. (NASDAQ:AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its upsized public offering of an aggregate of
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
Here's a roundup of top developments in the biotech space over the last 24 hours:
Field Trip Shares Fiscal Q4 And Full Year 2022 Results & Update On Court-Approved Corporate Reorganization
Psychedelic therapies developer and provider Field Trip Health Ltd.
Verrica Announces Proposed Public Offering of Common Stock, Terms Not Disclosed
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it intends to offer and sell, subject to
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
89bio Posts Promising Pegozafermin Data For Severe Hypertriglyceridemia
89bio Inc (NASDAQ: ETNB)
89bio Announces Proposed $75M Underwritten Public Offering
89bio, Inc. ("89bio") (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases,